Clinical Trial Update: Lansoprazole in Preterm Infants With Reflux [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lansoprazole for gastroesophageal reflux disease in preterm infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Preterm Infants, Gastrointestinal Reflux | Phase 2 | Status: COMPLETED